ahlam1399
08-29-2016, 11:13 AM
BRIEF-Erytech Pharma completes patient enrollment phase 2b trial for eryaspase
* Erytech completes patient enrollment in phase 2b trial foreryaspase (Graspa) in acute myeloid leukemiahttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=lZXzk35aIuw:6fuEHwOWxWY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lZXzk35aIuw:6fuEHwOWxWY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=lZXzk35aIuw:6fuEHwOWxWY:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lZXzk35aIuw:6fuEHwOWxWY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=lZXzk35aIuw:6fuEHwOWxWY:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/lZXzk35aIuw
* Erytech completes patient enrollment in phase 2b trial foreryaspase (Graspa) in acute myeloid leukemiahttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=lZXzk35aIuw:6fuEHwOWxWY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lZXzk35aIuw:6fuEHwOWxWY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=lZXzk35aIuw:6fuEHwOWxWY:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=lZXzk35aIuw:6fuEHwOWxWY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=lZXzk35aIuw:6fuEHwOWxWY:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/lZXzk35aIuw